Protagonist Therapeutics Inc (PTGX)
Free Cash Flow
$132.17M
TTM · Period ending: · USD
PTGX Free Cash Flow
Latest reported$132.17Mperiod ending
Latest reported$132.17Mperiod ending
PTGX TTM Free Cash Flow (-$14.78M → $132.17M)
TTM free cash flow
High-resolution chart · PNG
PTGX free cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 132,172,000 | |
| -116,305,000 | |
| 57,671,000 | |
| 63,712,000 | |
| 37,099,000 | |
| 335,286,000 | |
| 182,797,000 | |
| 229,226,000 | |
| 230,849,000 | |
| -64,159,000 | |
| -70,845,000 | |
| -119,491,000 | |
| -117,839,000 | |
| -105,350,000 | |
| -108,932,000 | |
| -104,362,000 | |
| -107,734,000 | |
| -118,009,000 | |
| -108,966,000 | |
| -100,823,000 | |
| -88,450,000 | |
| -85,865,000 | |
| -72,955,000 | |
| -68,470,000 | |
| -66,045,000 | |
| -41,652,000 | |
| -42,494,000 | |
| -38,184,000 | |
| -33,671,000 | |
| -51,915,000 | |
| -50,433,000 | |
| -54,441,000 | |
| -4,503,000 | |
| -1,736,000 | |
| 3,206,000 | |
| 7,679,000 | |
| -39,863,000 | |
| -35,265,000 | |
| -30,351,000 | |
| -25,578,000 | |
| -22,432,000 | |
| -17,836,000 | |
| -14,784,000 |